228 related articles for article (PubMed ID: 22154278)
41. Sharpening the attack on non-small cell lung cancer.
Alexander A; Quincy B
JAAPA; 2016 Nov; 29(11):1-5. PubMed ID: 27787282
[TBL] [Abstract][Full Text] [Related]
42. Molecular targeted therapy in lung cancer.
Fujioka N; Bitterman PB
Minn Med; 2012 Oct; 95(10):38-41. PubMed ID: 23193704
[TBL] [Abstract][Full Text] [Related]
43. Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) focus on tumor biology and biomarkers related to lung cancer.
Subramanian J; Corrales L; Soulieres D; Morgensztern D; Govindan R
J Thorac Oncol; 2011 Feb; 6(2):399-403. PubMed ID: 21206384
[TBL] [Abstract][Full Text] [Related]
44. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
Simon GR; Somaiah N
Clin Lung Cancer; 2014 Jan; 15(1):21-51. PubMed ID: 24377743
[TBL] [Abstract][Full Text] [Related]
45. Smokers have 10 times more genetic damage in lung cancer tumors.
Cancer; 2013 Jan; 119(2):248-9. PubMed ID: 23292898
[No Abstract] [Full Text] [Related]
46. Identification of driver mutations in lung cancer: first step in personalized cancer.
Planchard D
Target Oncol; 2013 Mar; 8(1):3-14. PubMed ID: 23371030
[TBL] [Abstract][Full Text] [Related]
47. Biomarkers and receptor targeted therapies reduce clinical trial risk in non-small-cell lung cancer.
Falconi A; Lopes G; Parker JL
J Thorac Oncol; 2014 Feb; 9(2):163-9. PubMed ID: 24419412
[TBL] [Abstract][Full Text] [Related]
48. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
Zarogoulidis P; Yarmus L; Zarogoulidis K
Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
[No Abstract] [Full Text] [Related]
49. Targeted therapies for advanced non-small cell lung cancer.
Ai X; Guo X; Wang J; Stancu AL; Joslin PMN; Zhang D; Zhu S
Oncotarget; 2018 Dec; 9(101):37589-37607. PubMed ID: 30680072
[TBL] [Abstract][Full Text] [Related]
50. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
Somaiah N; Simon NG; Simon GR
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S342-68. PubMed ID: 23160320
[No Abstract] [Full Text] [Related]
51. Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
Weiss GJ
J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S409-10. PubMed ID: 23160337
[No Abstract] [Full Text] [Related]
52. Current Landscape of Targeted Therapy in Lung Cancer.
Mayekar MK; Bivona TG
Clin Pharmacol Ther; 2017 Nov; 102(5):757-764. PubMed ID: 28786099
[TBL] [Abstract][Full Text] [Related]
53. Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer.
Carnio S; Novello S; Bironzo P; Scagliotti GV
Expert Rev Anticancer Ther; 2014 Dec; 14(12):1495-513. PubMed ID: 25183305
[TBL] [Abstract][Full Text] [Related]
54. Expanding targeted therapies for NSCLC.
Cancer Discov; 2014 Dec; 4(12):OF1. PubMed ID: 25477108
[TBL] [Abstract][Full Text] [Related]
55. The biology and management of non-small cell lung cancer.
Herbst RS; Morgensztern D; Boshoff C
Nature; 2018 Jan; 553(7689):446-454. PubMed ID: 29364287
[TBL] [Abstract][Full Text] [Related]
56. Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics.
Stella GM; Luisetti M; Pozzi E; Comoglio PM
Lancet Respir Med; 2013 May; 1(3):251-61. PubMed ID: 24429131
[TBL] [Abstract][Full Text] [Related]
57. Pharmacodynamic biomarkers: falling short of the mark?
Gainor JF; Longo DL; Chabner BA
Clin Cancer Res; 2014 May; 20(10):2587-94. PubMed ID: 24831281
[TBL] [Abstract][Full Text] [Related]
58. Personalized oncology in interventional radiology.
Abi-Jaoudeh N; Duffy AG; Greten TF; Kohn EC; Clark TW; Wood BJ
J Vasc Interv Radiol; 2013 Aug; 24(8):1083-92; quiz 1093. PubMed ID: 23885909
[TBL] [Abstract][Full Text] [Related]
59. Targeting signaling pathways in lung cancer therapy.
Cho WC
Expert Opin Ther Targets; 2013 Feb; 17(2):107-11. PubMed ID: 23231077
[TBL] [Abstract][Full Text] [Related]
60. Lung cancer: New biological insights and recent therapeutic advances.
Ramalingam SS; Owonikoko TK; Khuri FR
CA Cancer J Clin; 2011; 61(2):91-112. PubMed ID: 21303969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
